IL6 and COVID-19: These mechanisms are in line with the observed clinical markers in COVID-19, including high expression of inflammatory cytokines (i.e., TNF-α/IL-6), elevated leukocyte and neutrophil counts, and an elevated neutrophil-to-lymphocyte ratio (NLR) [7,31].